Cumulative sales of 3.3 million units in two years since launch

Large-scale human application trials are underway for the approval of individual functional ingredients for health functional foods.

[Bio Times] Kookmin Bio (CEO Moonhee Sung), a company specializing in R&D of bio-health food and pharmaceutical materials, announced on the 16th that its domestic plant-based food brand, Black Soybean Soymilk and SOYFROM convenience foods, have sold a cumulative total of 3.3 million units in two years since launch.

SOYFROM is a plant-based food brand that manufactures soy milk and grain shakes using domestically produced soybeans. The products are produced in a HACCP-certified factory based on the standardization of raw materials and processes at the GMP-certified facility of the Kookmin Bio Commercialization Center, a GMP-certified facility located in the Jeonbuk Special Zone.

Kookmin Bio has been certified by the Ministry of Agriculture, Food and Rural Affairs as a New Excellent Technology (NET) for its “Technology for Manufacturing Postbiotic Anti-obesity Products Using Domestic Soybean (Socheongja) Processed Powder and Bacillus Submerged Cultures (Metabolites).” Currently, the Kangbuk Samsung Hospital Department of Family Medicine is conducting a large-scale human application test for the approval of the reduction of body fat (including visceral fat) in 80 adult men and women aged 19 to 65 who have been diagnosed with obesity for the purpose of certifying individual functional ingredients for health functional foods.

The So-Phrum product uses black beans, which are a treasure of the soil grown in Jeonbuk, Korea. The isoflavones contained in black medicinal beans can help improve immunity and have anti-cancer effects. They also contain a large amount of dietary fiber, as well as plant-based protein that improves muscle strength and prevents cholesterol and skin problems, so they can be very helpful when used as a meal once a day.

In addition, Kookmin Bio Black Soybean Soymilk is known to raise blood sugar slowly, so it is said to be easy to control diabetes by preventing blood sugar spikes that occur rapidly after eating.

Kookmin Soybean Soymilk and Soyfirm products, which have sold more than 3.3 million units, include Kookmin Soybean Soymilk, which contains 100% domestically produced black soybean soybeans, and Soyfirm, which contains black soybean soybeans grown in Jeonbuk Province. Healthy plant-based protein snack 'Protein Bomb', effective body fat management snack 'Light & Balance', healthy meal replacement snack 'Milk Original' and so on.

Kookmin Bio received an excellent rating in the 2024 TIPS evaluation, and recently succeeded in attracting a series B investment of 3.4 billion won, bringing its cumulative investment to over 10 billion won.

The company is holding various events, including a 100% prize-winning deposit roulette event and a 110,000 won coupon pack giveaway, to celebrate the end of the year and the 3 million Soiprom sales milestone. For more information, please visit the Soifrom website, 'Soifrom Year-end Solution SET'.

Sung Moon-hee, CEO of Kookmin Bio (Ph.D. in Microbiology and Biochemistry, Emeritus Professor at Kookmin University) said, “Kookmin's Soybean Milk and Soflom have sold a cumulative total of 3.3 million units in just two years since their launch. In particular, we are pleased to have a customer satisfaction rating of 98.5%. Based on the patented microorganisms, lactic acid bacteria and bacillus, which were isolated independently from Korean fermented foods, we are developing an innovative disease-fighting intestinal microbe regulation technology that increases beneficial microbes in the gut and reduces harmful microbes by utilizing metabolites that are beneficial to the human body. Through this, we are doing our best to contribute to the improvement of the public health by developing microbiome-regulating bio-innovative new drugs and health functional foods that are effective in improving muscle strength, treating sarcopenia, reducing body fat (visceral fat), and treating abdominal obesity.